You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 7, 2024

Details for Patent: 10,959,991


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,959,991 protect, and when does it expire?

Patent 10,959,991 protects KATERZIA and is included in one NDA.

This patent has five patent family members in four countries.

Summary for Patent: 10,959,991
Title:Amlodipine formulations
Abstract: Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
Inventor(s): Brauer; Scott (Harrisonville, MO), Mosher; Gerold L. (Kansas City, MO)
Assignee: Silvergate Pharmaceuticals, Inc. (Greenwood Village, CO)
Application Number:16/927,664
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 10,959,991

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity KATERZIA amlodipine benzoate SUSPENSION;ORAL 211340-001 Jul 8, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ANGINA PECTORIS ⤷  Sign Up
Azurity KATERZIA amlodipine benzoate SUSPENSION;ORAL 211340-001 Jul 8, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ANGINA ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,959,991

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 3038989 ⤷  Sign Up
European Patent Office 3522872 ⤷  Sign Up
European Patent Office 3960158 ⤷  Sign Up
Spain 2886067 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2018067959 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.